Previous Close | 20.37 |
Open | 20.01 |
Bid | 19.66 x 900 |
Ask | 19.69 x 800 |
Day's Range | 19.52 - 20.01 |
52 Week Range | 13.92 - 28.18 |
Volume | |
Avg. Volume | 764,852 |
Market Cap | 1.583B |
Beta (5Y Monthly) | 1.76 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Myriad Genetics' (MYGN) significant gross margin contraction and operating loss as a result of mounting cost pressure are concerning.
Statistically speaking, long term investing is a profitable endeavour. But along the way some stocks are going to...
Halozyme Therapeutics (HALO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.